Vedolizumab Emerges as Option in IBD After Anti-TNF Failure Vedolizumab Emerges as Option in IBD After Anti-TNF Failure
The management of anti-TNF-resistant patients is an important clinical challenge, but new data suggest that vedolizumab helps mucosal healing in Crohn ' s disease and ulcerative colitis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Crohn's Disease | Gastroenterology | Health | Inflammatory Bowel Disease | Ulcerative Colitis